Evidence map›Paper›PMID 38672593›Full record

ArticleCancers2024

Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz, María José Calasanz, José Luis Vizmanos

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ana Guijarro-HernándezDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-1061-7744
Cristina HurtadoDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.
María José LarráyozCIMA LAB Diagnostics, Department of Biochemistry and Genetics, School of Sciences, University of Navarra, 31009 Pamplona, Spain.ORCID 0000-0003-0667-1959
María José CalasanzCIMA LAB Diagnostics, Department of Biochemistry and Genetics, School of Sciences, University of Navarra, 31009 Pamplona, Spain.ORCID 0000-0002-0374-3008
José Luis VizmanosDepartment of Biochemistry and Genetics, School of Sciences, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-7416-3679
Universidad de Navarra · ES

Funding

Fundación Universitaria de Navarra PIUNA 2020 Program No. 15058203
6 · The paper itself

Abstract

Essential thrombocythemia (ET) is a blood cancer caused by mutations in

Indexed as

CALRETmyeloproliferative neoplasmsRXRA

Identifiers

PMID38672593
PMCPMC11048154
OpenAlexW4394846272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.